Biolife Solutions (BLFS) Retained Earnings (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Retained Earnings of -$338.5 million for Q1 2026, down 0.88% year-over-year from -$341.5 million in Q1 2025, and down 256546.97% quarter-over-quarter from $132000.0 in Q4 2025.
Biolife Solutions (BLFS) Retained Earnings (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Retained Earnings for 17 consecutive years, with -$338.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 0.88% year-over-year to -$338.5 million; the TTM figure through Mar 2026 stood at -$338.5 million (down 0.88% YoY), while the FY2025 annual figure was $132000.0, up 100.04% from the prior year.
- Retained Earnings fell to -$338.5 million in Q1 2026 per BLFS's latest filing, from $132000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $132000.0 in Q4 2025 and bottomed at -$351.4 million in Q2 2025.
- Historically, Retained Earnings has averaged -$186.9 million across 5 years, with a median of -$197.7 million in 2022.
- Annual changes were most pronounced in 2024 — Retained Earnings sank 97030.72% — and 2025, when it jumped 100.04%.
- Biolife Solutions' Retained Earnings stood at -$679000.0 in 2022, then surged by 49.19% to -$345000.0 in 2023, then tumbled by 97030.72% to -$335.1 million in 2024, then surged by 100.04% to $132000.0 in 2025, then sank by 256546.97% to -$338.5 million in 2026.
- Business Quant data shows BLFS's Retained Earnings at -$338.5 million in Q1 2026, $132000.0 in Q4 2025, and -$350.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | -293.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -293.41 Mn |
| Mar 31, 2026 | -338.51 Mn |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | -350.77 Mn |
| Jun 30, 2025 | -351.39 Mn |
| Mar 31, 2025 | -335.55 Mn |
| Dec 31, 2024 | -335.10 Mn |
| Sep 30, 2024 | -347.56 Mn |
| Jun 30, 2024 | -345.86 Mn |
| Mar 31, 2024 | -566,000.00 |
| Dec 31, 2023 | -345,000.00 |
| Sep 30, 2023 | -660,000.00 |
| Jun 30, 2023 | -270.83 Mn |
| Mar 31, 2023 | -534,000.00 |
| Dec 31, 2022 | -679,000.00 |
| Sep 30, 2022 | -197.73 Mn |
| Jun 30, 2022 | -187.41 Mn |
| Mar 31, 2022 | -114.53 Mn |
| Dec 31, 2021 | -282,000.00 |
| Sep 30, 2021 | -90.55 Mn |